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background: The role of inferior vena cava (IVC) filter placement in cancer patients with proximal lower extremity deep vein thrombosis (DVT) is 
unknown.
Methods: We used the Nationwide Inpatient Sample database from 2005 to 2011 to identify 108,243 patients admitted with a principal 
discharge diagnosis of proximal lower extremity or caval DVT (ICD-9-CM 453.41, 453.2). From this cohort a total of 25,218 cancer patients were 
identified, of which 23.7% (5,977) underwent IVC filter placement. We evaluated the national trends in the utilization rates of IVC filter placement 
using unmatched patients. The comparative outcomes analysis was performed using propensity scores and Elixhauser comorbidity index to match 
the two treatment groups. After 1:1 matching, we compared in-hospital outcomes between 5,679 matched pairs of patients treated with (Group A) 
and without IVC filter placement (Group B).
results:  The national IVC filter placement rates have ranged from 22.5% to 23.2% (p=0.255) in these patients during the seven-year study period. 
The comparative outcomes analysis of the matched groups showed that in-hospital mortality was not significantly different between the two groups 
(Group A 2.1% vs. Group B 2.2%; p=0.75). The rates of blood transfusion (Group A 19.9% vs. Group B 13.6%; p<0.001) and pulmonary embolism 
(Group A 21.3% vs. Group B 15.1%; p<0.001) were significantly higher in Group A. The filter group also had increased length of stay (Group A 6.7±6.9 
vs. Group B 5.5±4.7 days; p<0.001) and hospital charges (Group A $ 50,077 ± 57000 vs. Group B $29159 ± 41609; p<0.001).
conclusions:  In this nationwide observational study, we found that in-hospital morbidity with IVC filters remained higher in cancer patients, 
however the in-hospital mortality was not significantly different between the two groups. We also found that IVC filter placement was associated with 
increased cost and healthcare resource utilization.
